Zoetis Inc.
ZTSPharma & biotechzoetis.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Nov 5, 2026
Next reportFebruary 10, 2027after close · forecast 1.312 $/share
Revenue
$2.39B
▼ -1.3% vs prior year YoY
Net income
$591.00M
▼ -18.0% vs prior year YoY
EPS
1.44$
▼ -11.7% vs prior year YoY
Net margin
24.7%
▼ -5.1 pp vs prior year YoY
Revenue▼ -1.3%
Margins (% of revenue)GrossOperating N/ANet
Net income▼ -18.0%
EPS▼ -11.7%
Financial statements
View 10-Q filed November 5, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $2.32B | $2.20B | $2.47B | $2.42B | $2.39B | $2.26B | $2.47B | $2.39B | ▼ -1.3% |
| Gross profit | $1.61B | $1.58B | $1.81B | $1.73B | $1.68B | $1.62B | $1.79B | $1.69B | ▼ -1.9% |
| Operating incomenever filed | — | — | — | — | — | — | — | — | — |
| Net income | $581.00M | $602.00M | $726.00M | $721.00M | $603.00M | $601.00M | $691.00M | $591.00M | ▼ -18.0% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 1.34 $ | 1.63 $ | 1.63 $ | — | 1.42 $ | 1.65 $ | 1.44 $ | ▼ -11.7% |
| Margins (% of revenue) | |||||||||
| Gross | 69.5 % | 71.9 % | 73.2 % | 71.2 % | 70.2 % | 71.7 % | 72.7 % | 70.8 % | ▼ -0.4 pt |
| Operating | — | — | — | — | — | — | — | — | — |
| Net | 25.1 % | 27.4 % | 29.3 % | 29.8 % | 25.3 % | 26.6 % | 28.0 % | 24.7 % | ▼ -5.1 pt |
| Balance sheet | |||||||||
| Assets | $14.24B | $14.10B | $14.48B | $15.16B | $15.49B | $15.15B | $15.08B | $15.09B | ▼ -0.5% |
| Liabilities | $9.47B | $9.44B | $9.50B | $9.76B | $12.07B | $11.92B | $11.93B | $11.79B | ▲ +20.7% |
| Equity | $4.77B | $4.66B | $4.98B | $5.40B | $3.42B | $3.23B | $3.15B | $3.30B | ▼ -38.8% |
| Cash | $1.99B | $1.72B | $1.44B | $2.08B | $2.45B | $1.94B | $1.48B | $1.33B | ▼ -36.0% |
| Capital | |||||||||
| Shares outstanding | 447.79M | 445.21M | 443.18M | 440.69M | 422.13M | 419.23M | 413.22M | 406.32M | ▼ -7.8% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.